艾德生物：股东厦门科英完成减持4775100股

Group 1 - The core point of the article is that Aide Biology announced a reduction in shareholding by its shareholder, Xiamen Keying Investment Partnership, which completed a plan to sell 4,775,100 shares, accounting for 1.22% of the total share capital [2] - The shareholding percentage of Xiamen Keying Investment Partnership decreased from 4.08% to 2.86% following the completion of the reduction plan [2]